Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

‘Africa’s Many Liberations’ seminar series launched
2016-05-11

Description: Seminar Series Tags: Seminar Series

The Africa’s Many Liberations seminar series, presented on the Bloemfontein Campus of the University of the Free State (UFS), is a direct response to some of the demands made by the #MustFall campaigns during the past year. A constant refrain among activists has been that the curriculum must be ‘decolonised’, and that it should have stronger foundations in African experiences. This seminar series aims to deepen understanding of histories and anti-colonial struggles, including those waged worldwide today.

It was conceived to deepen students’ knowledge of African and South African history, and to help them to engage with ideas from the diaspora and anti-colonial struggles elsewhere. It was planned as a popular seminar for students across faculties. For this reason, the series strives to avoid language or literature that might exclude students from disciplines outside of historical, sociological, political, and cultural studies.

The series is convened by the International Studies Group (ISG), in association with the Institute for Reconciliation and Social Justice (IRSJ). The coordinator is Prof Neil Roos (associate professor of history in the International Studies Group, and co-director of the Vice-Chancellor’s Prestige Scholars Programme).

Prof Roos presented the first seminar, entitled Du Bois and the ‘Problem of the Colour Line’ on Thursday 28 April 2016. The next theme under discussion will be Fanon and the Relevance of Personal and Collective Decolonisation in Today’s South Africa, which will be presented by Dr Tinashe Nyamunda.

The remainder of the eight-part series will be presented by Dr Rachel Hatcher (postdoc in the IRSJ), Dr Sahar Sattarzadeh (postdoc in the IRSJ ), Dr Ivo Mhike (postdoc in ISG), Busi Ntsele (lecturer in sociology), Leigh-Ann Naidoo (doctoral student and activist, University of the Witwatersrand, South Africa), and Prof Richard Pithouse (associate professor in politics, Rhodes University, South Africa).

Date: Thursday 12 May 2016
Time: 16:30
Venue: Albert Wessels Auditorium, Bloemfontein Campus
Entrance is free
RSVP: sattarzadehsd@ufs.ac.za

Seminar series programme

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept